000825810 000__ 02888cam\a2200469Ii\4500
000825810 001__ 825810
000825810 005__ 20230306144234.0
000825810 006__ m\\\\\o\\d\\\\\\\\
000825810 007__ cr\cn\nnnunnun
000825810 008__ 180125s2018\\\\sz\a\\\\ob\\\\000\0\eng\d
000825810 019__ $$a1021188295$$a1027013480
000825810 020__ $$a9783319625065$$q(electronic book)
000825810 020__ $$a3319625063$$q(electronic book)
000825810 020__ $$z9783319625058
000825810 0247_ $$a10.1007/978-3-319-62506-5$$2doi
000825810 035__ $$aSP(OCoLC)on1020319101
000825810 035__ $$aSP(OCoLC)1020319101$$z(OCoLC)1021188295$$z(OCoLC)1027013480
000825810 040__ $$aN$T$$beng$$erda$$epn$$cN$T$$dN$T$$dGW5XE$$dEBLCP$$dAZU$$dUAB$$dUPM$$dMERER$$dOCLCF$$dOCLCQ
000825810 049__ $$aISEA
000825810 050_4 $$aRC280.T6
000825810 08204 $$a616.99/444$$223
000825810 24500 $$aAtlas of thyroid and neuroendocrine tumor markers /$$cLuca Giovanella, editor.
000825810 264_1 $$aCham :$$bSpringer,$$c[2018]
000825810 264_4 $$c©2018
000825810 300__ $$a1 online resource :$$billustrations
000825810 336__ $$atext$$btxt$$2rdacontent
000825810 337__ $$acomputer$$bc$$2rdamedia
000825810 338__ $$aonline resource$$bcr$$2rdacarrier
000825810 347__ $$atext file$$bPDF$$2rda
000825810 504__ $$aIncludes bibliographical references.
000825810 506__ $$aAccess limited to authorized users.
000825810 520__ $$aThis book highlights the increase in thyroid tumors and NET and demonstrates the growing importance of circulating markers in diagnosis as well as treatment and follow-up. Dramatic technical improvements have heightened the clinical impact of well-established, conventional biochemical markers. In addition, more recent genetic and molecular approaches have provided innovative molecular markers. In this context, effective communication between clinicians and laboratory physicians/scientists is essential in allowing all those involved to fully profit from these exciting advances. In this comprehensive, up-to-date book, authors from different laboratory and clinical areas link laboratory and clinical topics. Analytical problems such as interferences, false-negative and false-positive results are discussed in depth, and flow-charts offer insights into identifying and avoiding them. Illustrated clinical cases detail the clinical role and limitations of different tumor markers. Lastly, it explores health technology assessment and economic issues. This is a valuable resource for endocrinologists, oncologists, nuclear medicine physicians, scientists and technologists who want to keep abreast of the latest developments.
000825810 588__ $$aOnline resource; title from PDF title page (viewed January 31, 2018).
000825810 650_0 $$aThyroid gland$$xTumors.
000825810 650_0 $$aNeuroendocrine tumors.
000825810 650_0 $$aTumor markers.
000825810 7001_ $$aGiovanella, Luca,$$eeditor.
000825810 77608 $$iPrint version: $$z9783319625058
000825810 852__ $$bebk
000825810 85640 $$3SpringerLink$$uhttps://univsouthin.idm.oclc.org/login?url=http://link.springer.com/10.1007/978-3-319-62506-5$$zOnline Access$$91397441.1
000825810 909CO $$ooai:library.usi.edu:825810$$pGLOBAL_SET
000825810 980__ $$aEBOOK
000825810 980__ $$aBIB
000825810 982__ $$aEbook
000825810 983__ $$aOnline
000825810 994__ $$a92$$bISE